Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd, a subsidiary of the Ipsen Group, donated 1 million yuan of Etiasa, the specialty medicine for inflammatory bowel disease (IBD), to Beijing Red Cross Foundation on Dec 16, aiming to help more IBD patients in China.

This is a nationwide campaign under the theme "In the Name of Love", which is held by both parties in the spirit of "humanity, love and dedication".

Beijing Red Cross Foundation will immediately distribute free Etiasa to IBD patients across China until Feb 28, 2011. IBD patients can apply for the medicine both online and at hospitals.